Imatinib

Part of speech: noun

Definitions

1. A medication used to treat certain types of cancer by inhibiting specific enzymes that promote abnormal cell growth ; a targeted therapy drug that blocks proteins involved in the growth of leukemia and some other tumors ; a pharmaceutical agent designed to interfere with cellular signals crucial for cancer cell proliferation and survival
2. A drug prescribed primarily for chronic myeloid leukemia and gastrointestinal stromal tumors ; a selective inhibitor of tyrosine kinases that prevents cancer cells from multiplying ; a treatment option that disrupts abnormal enzyme activity to control malignant cell expansion
3. A therapeutic compound that targets and blocks enzyme activity in cancerous cells to slow disease progression ; a small molecule cancer treatment effective against diseases caused by overactive protein kinases ; an agent used in oncology to inhibit enzymes essential for tumor cell survival and replication

Etymology: Imatinib is a coined pharmaceutical name, and its history lives in its suffix rather than in any older English or classical root. The ending "-tinib" is a naming convention for drugs that block tyrosine kinases, enzymes that signal cells to grow and divide. Pharmaceutical companies use these standardized endings so that a clinician can tell from the name alone which class of drug a compound belongs to, much as "-statin" marks cholesterol-lowering drugs. The stem "imat-" carries no independent meaning in English and was chosen as a distinctive, pronounceable syllable for the compound itself. The name therefore works as a label built from a class marker plus a unique prefix, not as a word that drifted from an earlier sense. Its origin is a deliberate invention of modern drug nomenclature.

Synonyms: gleevec